Ackman's Pershing Square makes $3.3 billion bet on Valeant -- Reuters

Billionaire investor William Ackman has purchased a five percent stake in Valeant Pharmaceuticals, his hedge fund said on Monday, making him the Canadian drug company's fifth-largest stakeholder, Reuters News reported.

DealsNorth AmericaUSBriefs